Concepedia

Combined treatment with LDL-apheresis, chenodeoxycholic acid and HMG-CoA reductase inhibitor for cerebrotendinous xanthomatosis

Shoichi Ito, Satoshi Kuwabara, Ryuji Sakakibara, Takeshi Oki, Hiroshi Arai, Shigeto Oda, Takamichi Hattori

Journal of the Neurological Sciences · 2003 · 31 citations · 11 references

DOI

Concepts

References

11

Handbook of clinical neurology

Theodore L. Munsat · Neuromuscular Disorders · 1993 · 553 citations

, , +12

Long-Term Treatment of Cerebrotendinous Xanthomatosis with Chenodeoxycholic Acid

Vladimir M. Berginer, Gerald Salen, Sarah Shefer · New England Journal of Medicine · 1984 · 389 citations

, , +10

Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.

H Oftebro, Ingemar Björkhem, Steinar Skrede et al. · Journal of Clinical Investigation · 1980 · 230 citations · Full text

, , +16

Cholestanol Deposition in Cerebrotendinous Xanthomatosis

Gerald Salen · Annals of Internal Medicine · 1971 · 230 citations

, , +17

Cerebrotendinous Xanthomatosis

John H. Menkes · Archives of Neurology · 1968 · 171 citations

, , +16